REVIEW
Add like
Add dislike
Add to saved papers

Magnetic resonance appearance of uncomplicated Paget's disease of bone.

Paget's disease is a disorder of the bone mesenchyma of the skeleton and is a unique condition in which active bone changes can occur without concomitant significant marrow alteration. When present, marrow changes involve predominantly the paratrabecular and endosteal areas, where bone metabolism is increased. At magnetic resonance (MR) imaging, marrow alterations can become prominent and hence confusing in bones with high trabecular content including vertebrae and pelvis. This article addresses the MR appearance of uncomplicated Paget's disease, including normal pagetic bone, predominantly lytic or sclerotic pagetic bone, and unusual partial involvement of the vertebral body. We will emphasize the added diagnostic value of the combination of imaging techniques that depict either osseous changes including radiographs, computed tomography, and bone scintigraphy, or marrow changes, including MR imaging, to contribute to a noninvasive presumptive diagnosis of Paget's disease in atypical presentations.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app